NVIDIA Teams Up with Eli Lilly to Set Up an AI-Powered Drug Research Lab, Pledging US$1 Billion Investment Over Five Years
3 week ago / Read about 0 minute
Author:小编   

On January 12, 2026, NVIDIA and Eli Lilly unveiled plans to establish a cutting-edge joint innovation lab focused on artificial intelligence (AI) in drug research. The two industry giants will collectively invest US$1 billion over the next five years, channeling funds into state-of-the-art infrastructure and groundbreaking research. This ambitious collaboration aims to revolutionize the pharmaceutical sector by harnessing AI's potential to speed up drug development processes, boost the effectiveness of new treatments, and minimize the industry's reliance on traditional, labor-intensive physical experiments.

  • C114 Communication Network
  • Communication Home